2023-10-01 2024-09-30 false Capium Accounts Production 1.1 07792526 2023-10-01 2024-09-30 07792526 bus:FullAccounts 2023-10-01 2024-09-30 07792526 bus:Micro-entities 2023-10-01 2024-09-30 07792526 bus:AuditExempt-NoAccountantsReport 2023-10-01 2024-09-30 07792526 bus:SmallCompaniesRegimeForAccounts 2023-10-01 2024-09-30 07792526 bus:PrivateLimitedCompanyLtd 2023-10-01 2024-09-30 07792526 2023-10-01 2024-09-30 07792526 2024-09-30 07792526 bus:RegisteredOffice 2023-10-01 2024-09-30 07792526 core:WithinOneYear 2024-09-30 07792526 core:AfterOneYear 2024-09-30 07792526 1 2023-10-01 2024-09-30 07792526 bus:Director1 2023-10-01 2024-09-30 07792526 bus:Director1 2024-09-30 07792526 bus:Director1 2022-10-01 2023-09-30 07792526 2022-10-01 07792526 bus:LeadAgentIfApplicable 2023-10-01 2024-09-30 07792526 2022-10-01 2023-09-30 07792526 2023-09-30 07792526 core:WithinOneYear 2023-09-30 07792526 core:AfterOneYear 2023-09-30 07792526 bus:EntityAccountantsOrAuditors 2022-10-01 2023-09-30 07792526 core:FurnitureFittings 2023-10-01 2024-09-30 07792526 core:FurnitureFittings 2024-09-30 07792526 core:FurnitureFittings 2023-09-30 07792526 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2024-09-30 07792526 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2023-09-30 07792526 core:CostValuation core:Non-currentFinancialInstruments 2024-09-30 07792526 core:CostValuation core:Non-currentFinancialInstruments 2023-09-30 07792526 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2024-09-30 07792526 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2024-09-30 07792526 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2024-09-30 07792526 core:Non-currentFinancialInstruments 2024-09-30 07792526 core:Non-currentFinancialInstruments 2023-09-30 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 07792526
England and Wales

 

 

 

YOSHE CLINICAL OPERATIONS LIMITED


Unaudited Financial Statements
 


Period of accounts

Start date: 01 October 2023

End date: 30 September 2024
Director Singaiah Kukkapalli
Registered Number 07792526
Registered Office Spaces, The Portal Building
1 Brunel way,
Slough
SL1 1FQ
Accountants ASK ACCOUNTANTS UK LTD
178
Merton High Street
London
SW19 1AY
1
  2024   2023
    £ £   £ £
Fixed assets   4,168      6,441 
Current assets 14,125      26,165   
Creditors: amount falling due within one year (12,270)     (23,256)  
Net current assets   1,855      2,909 
Total assets less current liabilities   6,023      9,350 
Provisions for liabilities   (374)     (374)
Net assets   5,649      8,976 
 

         
Capital and reserves   5,649      8,976 
 
NOTES TO THE ACCOUNTS

General Information
YOSHE CLINICAL OPERATIONS LIMITED is a private company, limited by shares, registered in England and Wales, registration number 07792526, registration address Spaces, The Portal Building, 1 Brunel way,, Slough, SL1 1FQ.

The presentation currency is £ sterling.
1.

Accounting policies

Significant accounting policies
Statement of compliance
These financial statements have been prepared in compliance with FRS 105 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.
Basis of preparation
The financial statements have been prepared under the historical cost convention as modified by the revaluation of land and buildings and certain financial instruments measured at fair value in accordance with the accounting policies.
The financial statements are prepared in sterling which is the functional currency of the company.
Turnover
Turnover comprises the invoiced value of goods and services supplied by the company, net of Value Added Tax and trade discounts.
Tangible fixed assets
Tangible fixed assets, other than freehold land, are stated at cost or valuation less depreciation and any provision for impairment. Depreciation is provided at rates calculated to write off the cost or valuation of fixed assets, less their estimated residual value, over their expected useful lives on the following basis:
Fixtures and Fittings 25% Straight Line
Provisions
Provisions are recognised when the company has a present obligation as a result of a past event which it is more probable than not will result in an outflow of economic benefits that can be reasonably estimated.
2.

Tangible fixed assets

Cost or valuation Fixtures and Fittings   Total
  £   £
At 01 October 2023 8,362    8,362 
Additions (609)   (609)
Disposals  
At 30 September 2024 7,753    7,753 
Depreciation
At 01 October 2023 1,921    1,921 
Charge for year 1,664    1,664 
On disposals  
At 30 September 2024 3,585    3,585 
Net book values
Closing balance as at 30 September 2024 4,168    4,168 
Opening balance as at 01 October 2023 6,441    6,441 


3.

Average number of employees

Average number of employees during the year was 6 (2023 : 5).

4.

Advances and Credits



Advance
Included within Debtors are the following loan to the director:

Current year (2024)
Brought Forward
£
Amount
£
Interest
£
Repaid
£
Written Off
£
Waived
£
Carry Forward
£
Advance
0000000
Previous year (2023)
Brought Forward
£
Amount
£
Interest
£
Repaid
£
Written Off
£
Waived
£
Carry Forward
£
Advance1,929 1,929 
0192901929000

For the year ended 30 September 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's Responsibilities:
The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.

The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.

These accounts have been prepared in accordance with the micro-entity provisions and FRS 105, the Financial Reporting Standard applicable to the micro-entities regime. The accounts have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. The income statement has not been delivered to the Registrar of Companies.
The financial statements were approved by the director on 08 May 2025 and were signed by:


--------------------------------
Singaiah Kukkapalli
Director
2